Latest AI and machine learning research in skin cancer for healthcare professionals.
Tertiary lymphoid structures (TLS) have been observed in solid tumors and have been associated with better outcomes in patients treated with immunotherapy, but their dynamic nature makes identifying TLS in clinical samples challenging. Recently, pathology foundation models have emerged as powerful tools in computational pathology. In this study, we aimed to develop a computational tool capable of ...
Immune checkpoint blockade has emerged as a promising form of cancer therapy. However, only some patients respond to checkpoint inhibitors, while a significant proportion of patients do not, calling for the discovery of reliable biomarkers. Recent studies reported the importance of the gut microbiome in the clinical response to PD-1 blockade against non-small cell lung cancer (NSCLC), highlighting...
The rational design of small molecules is central to drug discovery, yet current artificial intelligence (AI) methodologies for generating three-dimen...
Decoding cellular systems requires integrating diverse omics data, yet most models are trained from scratch on a single modality, restricting generali...
Biomarker discovery for immunotherapy often requires reasoning across complex immune contexts. We present IMMUNIA, a multi-large-language-model (multi...
Class I major histocompatibility complexes (MHCs), expressed on the surface of all nucleated cells, present peptides derived from intracellular protei...
This work introduces a modular, open-source computational pipeline for glioblastoma (GBM) vaccine design that integrates omics-based OIP5 target disco...
Stain imputation in multiplex immunofluorescence (mIF) imaging addresses the challenge of missing or damaged biomarker channels by reconstructing targ...
Synthetic enhancers with high specificity are crucial for therapeutic gene control. Although existing experimental screens and machine learning-based ...
This work introduces a modular, open-source computational pipeline for glioblastoma (GBM) vaccine design that integrates omics-based OIP5 target disco...
Single-cell RNA sequencing technologies have revolutionized our understanding of cellular heterogeneity, yet computational methods often struggle to b...
Melanoma outcomes have dramatically improved over the past decade, but some patients still experience disease recurrence, particularly those who prese...
Multiplexed imaging technologies now enable the simultaneous profiling of hundreds to thousands of molecular targets in intact tissues, providing unpr...
Digital pathology has significantly advanced cancer diagnosis by enabling high-resolution visualisation and assessment of tissue specimens. However, t...
Decisions on the best available treatment in clinical oncology are based on expert opinions in multidisciplinary cancer conferences (MCC). Artificial ...
To evaluate the potential of wrist-worn wearable devices to detect and quantify Faciobrachial Dystonic Seizures (FBDS) and related events associated w...
To synthesize existing literature on patient attitudes toward AI in cancer care and identify knowledge gaps that can inform future research and clinic...
Neoantigens have emerged as promising targets for personalized cancer immunotherapy. However, accurate identification of immunogenic neoantigens remai...
Patients with rare cancers face substantial challenges due to limited evidence-based treatment options, resulting from sparse clinical trials. Advance...
Merkel cell carcinoma (MCC) is a rare cutaneous neuroendocrine malignancy with a higher case-fatality rate than melanoma. The prognosis of MCC is comp...